Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Budman

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
The American Journal of Medicine|January 1, 1984
Dysmyelopoietic syndrome. Current conceptsT Degnan, L Weiselberg, P Schulman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase I evaluation of divided-dose vinblastine sulfateP Schulman, D R Budman, V Vinciguerra, et al.
Cancer Treatment Reports|January 1, 1982
Phase I trial of spirogermanium given by infusion in a multiple-dose scheduleD R Budman, P Schulman, V Vinciguerra, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
Implications of applied research for prognosis and therapy of breast cancerM F Barginear, T Bradley, I Shapira, et al.
Onkologie|December 1, 1988
Rapid rise of serum testosterone following discontinuation of long term treatment of prostate carcinoma with an LHRH-agonistW Kreis, D R Budman, P Delli Bovi, et al.
Lancet (London, England)|November 24, 1979
B-cell activation in angioimmunoblastic lymphadenopathy after immunisation with multivalent pneumococcal polysaccharide vaccineP Schulman, D R Budman, V P Vinciguerra, et al.
Cancer Research|February 15, 1997
Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cellsL G Wang, X M Liu, W Kreis, et al.
The American Journal of Medicine|January 1, 1979
Massive lymphadenopathy mimicking lymphoma in leukemic reticuloendotheliosisD R Budman, B Koziner, Z Arlin, et al.
Biochemical Pharmacology|September 14, 1999
Synergistic effect of estramustine and [3'-keto-Bmtl]-[Val2]-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cellsL G Wang, X M Liu, D R Budman, et al.
Biochemical and Biophysical Research Communications|May 21, 1999
Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activityL G Wang, X M Liu, W Kreis, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
The American Journal of Medicine|January 1, 1984
Dysmyelopoietic syndrome. Current conceptsT Degnan, L Weiselberg, P Schulman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase I evaluation of divided-dose vinblastine sulfateP Schulman, D R Budman, V Vinciguerra, et al.
Cancer Treatment Reports|January 1, 1982
Phase I trial of spirogermanium given by infusion in a multiple-dose scheduleD R Budman, P Schulman, V Vinciguerra, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
Implications of applied research for prognosis and therapy of breast cancerM F Barginear, T Bradley, I Shapira, et al.
Onkologie|December 1, 1988
Rapid rise of serum testosterone following discontinuation of long term treatment of prostate carcinoma with an LHRH-agonistW Kreis, D R Budman, P Delli Bovi, et al.
Lancet (London, England)|November 24, 1979
B-cell activation in angioimmunoblastic lymphadenopathy after immunisation with multivalent pneumococcal polysaccharide vaccineP Schulman, D R Budman, V P Vinciguerra, et al.
Cancer Research|February 15, 1997
Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cellsL G Wang, X M Liu, W Kreis, et al.
The American Journal of Medicine|January 1, 1979
Massive lymphadenopathy mimicking lymphoma in leukemic reticuloendotheliosisD R Budman, B Koziner, Z Arlin, et al.
Biochemical Pharmacology|September 14, 1999
Synergistic effect of estramustine and [3'-keto-Bmtl]-[Val2]-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cellsL G Wang, X M Liu, D R Budman, et al.
Biochemical and Biophysical Research Communications|May 21, 1999
Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activityL G Wang, X M Liu, W Kreis, et al.
Pageof 11